Immune checkpoint inhibitor trials for Non-Small-Cell Lung Cancer

All Immune checkpoint inhibitor trials · All Non-Small-Cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Immune checkpoint inhibitor for Non-Small-Cell Lung Cancer

• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer
  NCT05059951 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
  NCT06730503 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
  NCT06388031 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
  NCT05522660 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations

Common questions

How many trials study Immune checkpoint inhibitor for Non-Small-Cell Lung Cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.